Olmesartan Medoxomil
Who holds supplier records for Olmesartan Medoxomil? 37 organisations hold a current record for Olmesartan Medoxomil: an active US FDA Type II Drug Master File or a CEP. A further 12 organisations have only historical (inactive) DMF filings. 31 of them hold a valid EU Certificate of Suitability (32 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (23), China (8), Hungary (1), Netherlands (1) and 3 other countries (3); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Olmesartan Medoxomil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/olmesartan-medoxomil
Reading the evidence
- 37 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
23 of the 36 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 17 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (37)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Olmesartan Medoxomil. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 26035, 40890 · latest filing Mar 2025
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 24671 · latest filing Feb 2011
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 19141 · latest filing Jan 2006
- Cadila Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 22861 · latest filing Aug 2009
- CHIERON ACTIVE INGREDIENTS PRIVATE LTDIndiaCEPActive DMF 23153 · latest filing Sept 2009
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPActive DMF 33587 · latest filing Apr 2019
- EUROAPI HUNGARY LTDHungaryCEPActive DMF 28444 · latest filing Jul 2014
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 26992 · latest filing Mar 2013
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 26929 · latest filing Mar 2013
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 26318 · latest filing Sept 2012
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 20417 · latest filing Mar 2007
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 27539 · latest filing Sept 2013
- MOREPEN LABORATORIES LTDIndiaCEP Company GMP cert on recordActive DMF 36555 · latest filing Dec 2021
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 23690 · latest filing Apr 2010
- Shandong Anxin Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 29640 · latest filing Aug 2015
- TAPI NL BVNetherlandsCEPActive DMF 21931 · latest filing Sept 2008
- Torrent PharmaceuticalsIndiaCEP Company GMP cert on recordActive DMF 24180 · latest filing Sept 2010
- VASUDHA PHARMA CHEM LTDIndiaCEPActive DMF 38015, 29113 · latest filing Feb 2023
- Viyash Scientific LtdIndiaCEP Company GMP cert on recordActive DMF 38529 · latest filing Apr 2024
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 26143 · latest filing Apr 2012
- Zhejiang Tianyu Pharmaceutical Co., Ltd.ChinaCEPActive DMF 31888 · latest filing Feb 2018
- ZHUHAI RUNDU PHARMACEUTICAL CO LTDChinaCEPActive DMF 34941 · latest filing Dec 2020
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 24644 · latest filing Feb 2011
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 27164 · latest filing May 2013
- Ctx LifesciencesIndiaActive DMF 39841 · latest filing Apr 2024
- Divis LaboratoriesIndia Company GMP cert on recordActive DMF 27950 · latest filing Jan 2014
- Granules India LimitedIndia Company GMP cert on recordActive DMF 36865 · latest filing Mar 2022
- Shanghai Desano Chemical Pharmaceutical Co., LtdChinaActive DMF 44731 · latest filing Sept 2026
- ULKAR KIMYA SANAYII VE TICARET ASActive DMF 25860 · latest filing Mar 2012
- IndiaCEP
- ChinaCEP Company GMP cert on record
- ChinaCEP
- DONGBANG FUTURE TECH & LIFE CO., LTD.South KoreaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- YANTAI VALIANT PHARMACEUTICAL CO. LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- CPL PHARMACEUTICALS PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- Interquim, S.A.SpainCEPValid CEP holder (EDQM); not necessarily the manufacturer
- KRKA, d.d.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (32)
Certificates of Suitability on the EDQM register for Olmesartan Medoxomil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 54 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2012-043 - Rev 06 Olmesartan medoxomil | Sept 2026 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2014-196 - Rev 04 Olmesartan medoxomil | Sept 2026 | — |
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2023-253 - Rev 02 Olmesartan medoxomil | Jul 2026 | — |
| TORRENT PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2023-126 - Rev 01 Olmesartan medoxomil | Jul 2026 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2020-112 - Rev 05 Olmesartan medoxomil, Process II | Jul 2026 | — |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | CEP 2026-148 - Rev 00 Olmesartan medoxomil, Process-III | Jun 2026 | — |
| ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai | CN | CEP 2026-083 - Rev 00 Olmesartan medoxomil, Process 2 | Jun 2026 | — |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2012-228 - Rev 03 Olmesartan medoxomil | May 2026 | — |
| CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad | IN | CEP 2018-232 - Rev 03 Olmesartan medoxomil | Apr 2026 | — |
| DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-Si | KR | CEP 2015-237 - Rev 02 Olmesartan medoxomil | Mar 2026 | — |
| YANTAI VALIANT PHARMACEUTICAL CO. LTD. Yantai | CN | CEP 2024-350 - Rev 01 Olmesartan medoxomil, Micronised | Feb 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2013-297 - Rev 02 Olmesartan medoxomil | Jan 2026 | — |
| CPL PHARMACEUTICALS PRIVATE LIMITED Ahmedabad | IN | CEP 2025-511 - Rev 00 Olmesartan medoxomil, Process-II, Micronised, non-micronised | Jan 2026 | — |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2013-325 - Rev 02 Olmesartan medoxomil | Jan 2026 | — |
| EUROAPI HUNGARY Ltd. Budapest | HU | CEP 2013-105 - Rev 04 Olmesartan medoxomil | Jun 2025 | Inspected Jul 2026 Hungary |
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | CEP 2018-083 - Rev 04 Olmesartan medoxomil | Apr 2025 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2024-040 - Rev 00 Olmesartan medoxomil, OQ process, crystalline form | Mar 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2012-170 - Rev 02 Olmesartan medoxomil | Mar 2025 | — |
| ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2013-268 - Rev 03 Olmesartan medoxomil | Mar 2025 | — |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | CEP 2012-070 - Rev 02 Olmesartan medoxomil, Micronised and non-micronised | Mar 2025 | — |
| HEC PHARM CO., LTD. Yidu City | CN | CEP 2016-032 - Rev 02 Olmesartan medoxomil | Jan 2025 | Inspected Nov 2025 Germany |
| CADILA PHARMACEUTICALS LIMITED Ankleshwar | IN | CEP 2022-427 - Rev 00 Olmesartan medoxomil | Sept 2024 | — |
| MOREPEN LABORATORIES LIMITED Baddi | IN | CEP 2021-485 - Rev 00 Olmesartan medoxomil | Sept 2024 | Inspected Mar 2026 Spain |
| VASUDHA PHARMA CHEM LIMITED Hyderabad | IN | CEP 2015-076 - Rev 03 Olmesartan medoxomil | Aug 2024 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R1-CEP 2015-383 - Rev 00 Olmesartan medoxomil | Feb 2023 | — |
| MICRO LABS LIMITED Bengaluru | IN | R1-CEP 2014-251 - Rev 01 Olmesartan medoxomil | Jan 2023 | — |
| Interquim, S.A. Sant Cugat Del Vallès | ES | R1-CEP 2014-295 - Rev 01 Olmesartan medoxomil | Dec 2022 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R0-CEP 2022-194 - Rev 00 Olmesartan medoxomil, Process II | Sept 2022 | — |
| SECOND PHARMA CO., LTD. Shangyu City | CN | R1-CEP 2014-322 - Rev 01 Olmesartan medoxomil | May 2022 | — |
| SHANDONG ANXIN PHARMACEUTICAL CO., LTD. Dongjia Town | CN | R1-CEP 2014-225 - Rev 00 Olmesartan medoxomil | Jan 2022 | — |
| KRKA, d.d., Novo mesto Novo mesto | SI | R1-CEP 2015-259 - Rev 00 Olmesartan medoxomil | Sept 2021 | — |
| ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Sanzao Town | CN | R1-CEP 2014-121 - Rev 01 Olmesartan medoxomil | Jan 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (12)
Organisations whose Type II DMFs for Olmesartan Medoxomil are no longer active. These show a past filing, not current supply.
Show all 12 historical records
- India · Inactive DMF 30433 · filed Mar 2016
- India · Inactive DMF 29026 · filed Feb 2015
- India · Inactive DMF 26782 · filed Apr 2013
- QILU TIANHE PHARMACEUTICAL CO LTDInactive DMF 26420 · filed Sept 2012
- India · Inactive DMF 26198 · filed Jul 2012
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 25494 · filed Nov 2011
- RANBAXY LABORATORIES LTDInactive DMF 24432 · filed Dec 2010
- India · Inactive DMF 19384, 23658 · filed Mar 2010
- India · Inactive DMF 23617 · filed Mar 2010
- Amino Chemicals LtdMalta · Inactive DMF 22721 · filed Apr 2009
- Japan · Inactive DMF 14953 · filed Jul 2000
- SankyoInactive DMF 11433 · filed Apr 1995
Overview
Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) used to treat high blood pressure by relaxing blood vessels so that blood can flow more easily. It helps prevent strokes, heart attacks, and kidney problems by reducing the risk of cardiovascular events.
Chemical identity
- IUPAC name
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
- Canonical SMILES
- CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
- InChIKey
- UQGKUQLKSCSZGY-UHFFFAOYSA-N
- Synonyms
- Benicar API, azor component olmesartan medoxomil, benicar, cs-866, nsc-758924, olmetec, tribenzor component olmesartan medoxomil
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin 2 Receptor Blocker
- Mechanism of action
- Angiotensin 2 Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Olmesartan Medoxomil?
37 organisations hold an active US FDA Type II Drug Master File or a CEP for Olmesartan Medoxomil: APITORIA PHARMA PRIVATE LTD (India), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), Cadila Pharmaceuticals Limited (India), CHIERON ACTIVE INGREDIENTS PRIVATE LTD (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), EUROAPI HUNGARY LTD (Hungary) and Hetero Labs Limited (India), and 29 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Olmesartan Medoxomil Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 26035, 40890), Alembic Pharmaceuticals Limited (DMF 24671), ALIVUS LIFE SCIENCES LTD (DMF 19141), Cadila Pharmaceuticals Limited (DMF 22861), CHIERON ACTIVE INGREDIENTS PRIVATE LTD (DMF 23153), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 33587), EUROAPI HUNGARY LTD (DMF 28444) and Hetero Labs Limited (DMF 26992) and 21 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Olmesartan Medoxomil records mean?
12 organisations have only inactive Type II DMFs for Olmesartan Medoxomil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Olmesartan Medoxomil have a European Certificate of Suitability?
Yes. 31 organisations hold a valid CEP for Olmesartan Medoxomil on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), TORRENT PHARMACEUTICALS LIMITED Ahmedabad (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and AMOLI ORGANICS PRIVATE LIMITED Mumbai (IN) and 26 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Olmesartan Medoxomil supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Olmesartan Medoxomil?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.